TARRYTOWN, N.Y., Nov. 1 /PRNewswire-FirstCall/ -- Emisphere Technologies, Inc. will hold a conference call to discuss the Company’s financial results for the quarter ended September 30, 2005. The call will be held on Thursday, November 10, 2005, beginning at 10:30 a.m. Eastern Standard Time (7:30 a.m. Pacific). A replay of the call will be accessible approximately two hours following the end of the call and will be archived through November 17, 2005.
The live conference call dial-in number is: 800-963-8290 (U.S./Canada) 973-935-8502 (international) To access a replay of the call: 877-519-4471 (U.S./Canada) 973-341-3080 (international) Conference ID: 6610440
Emisphere will be simultaneously webcasting this teleconference. To access the live broadcast in listen-only mode, please go to the investor relations portion of the Company’s website at http://www.emisphere.com/ir.asp. Please visit the site at least five minutes prior to start time for instructions. A replay of the call will also be available on the Company’s website through November 17, 2005.
About Emisphere Technologies, Inc.
Emisphere Technologies, Inc. is a biopharmaceutical company pioneering the oral delivery of otherwise injectable drugs. Emisphere’s business strategy is to develop oral forms of injectable drugs, either alone or with corporate partners, by applying its proprietary eligen(R) technology to those drugs or licensing its eligen(R) technology to partners who typically apply it directly to their marketed drugs. Emisphere’s eligen(R) technology has enabled the oral delivery of proteins, peptides, macromolecules and charged organics. Emisphere and its partners have advanced oral formulations or prototypes of salmon calcitonin, heparin, insulin, parathyroid hormone, human growth hormone and cromolyn sodium into clinical trials. Emisphere has strategic alliances with world-leading pharmaceutical companies. For further information, please visit http://www.emisphere.com.
Emisphere Technologies, Inc.
CONTACT: Gillian Racine, Associate, Investor Relations of EmisphereTechnologies, Inc., +1-914-593-8332, gracine@emisphere.com